Hikma Pharmaceutical | Ativo Circulante



Current Assets Alterar Data
Almirall EUR 741.14M 47.91M 2024-12
argenx SE 4.88B 4.46B 2024-12
AstraZeneca USD 26.14B 312M 2025-03
Autolus Therapeutics Ltd 615.77M 45.16M 2025-03
Bayer EUR 34.83B 388M 2025-03
Fresenius EUR 11.91B 462M 2025-03
Galapagos EUR 3.47B 132.9M 2025-03
Genmab DKK 4.04B 23.82B 2025-03
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
GRIFOLS EUR 5.64B 87.54M 2025-03
Hikma Pharmaceutical USD 2.26B 22M 2024-12
Lonza CHF 5.44B 113M 2024-12
Merck EUR 12.41B 1.04B 2025-03
Orion EUR 1.08B 67.7M 2025-03
Recordati EUR 1.57B 310.28M 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 44.02B 1.43B 2025-03
UCB EUR 4.79B 1.47B 2024-12



Hikma Pharmaceutical Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.